MedReview we reassign, resulting in the highest savings per review and the lowest appeal overturn rate in the industry they are used into principle sources increased advanced algorithms are enriched by machine learning and decades of clinical and claims data, enabling us to target claims with the highest potential for inaccuracy and abuse ensuring